Requires Director of Division of Taxation to include sales of properties in age-restricted developments by third parties in table of equalized valuations.
Impact
The bill is expected to significantly impact state laws surrounding the operations of pharmacy benefit managers by adding stricter compliance regulations. By requiring timely payment and transparency in the pricing mechanisms used by PBMs, this bill seeks to mitigate the barriers that pharmacies face when submitting claims. Additionally, it enhances the rights of consumers by ensuring that they receive timely information regarding their claims. Overall, this legislative effort is oriented towards fostering a more reliable healthcare environment for patients and pharmacies alike.
Summary
Bill S464 seeks to improve the transparency and accountability of pharmacy benefit managers (PBMs) in the state of New Jersey. Key provisions require PBMs to ensure that all pharmacy claims are either paid or reimbursed within 14 calendar days of receipt, or that pharmacies receive written notification if claims are contested or denied. Furthermore, this legislation mandates annual audits of PBMs by the Department of Banking and Insurance to enforce compliance with these new requirements. Through these measures, the bill aims to enhance consumer confidence in the prescription drug reimbursement process.
Sentiment
The sentiment surrounding S464 is largely positive among advocates who see it as a necessary reform in the often opaque operations of pharmacy benefit managers. Supporters argue that the bill provides much-needed consumer protections and promotes fair practices within the pharmaceutical industry. Critics, however, express concerns regarding the potential costs of implementing these requirements on pharmacies, especially smaller entities, which may face challenges in accommodating new regulatory standards.
Contention
One notable point of contention regarding S464 is its potential impact on the operational flexibility of pharmacy benefit managers. While proponents argue that the bill will promote fairness and accountability, opponents indicate that the increased compliance burdens may inadvertently lead to higher costs for pharmacies and, ultimately, consumers. The debate highlights the tension between ensuring profitability and efficiency for PBMs while maintaining stringent regulatory standards aimed at protecting the consumer welfare.
Same As
Requires Director of Division of Taxation to include sales of properties in age-restricted developments by third parties in table of equalized valuations.
Carry Over
Requires Director of Division of Taxation to include sales of properties in age-restricted developments by third parties in table of equalized valuations.
Carry Over
Requires Director of Division of Taxation to include sales of properties in age-restricted developments by third parties in table of equalized valuations.
Requires Director of Division of Taxation to include sales of properties in age-restricted developments by third parties in table of equalized valuations.
Requires Director of Division of Taxation to include sales of properties in age-restricted developments by third parties in table of equalized valuations.
Requires Director of Division of Taxation to conduct study on impact of State business income taxation on business out-migration, formation, and employment for previous and upcoming tax years.
Requires Director of Division of Taxation to study impact of State business income taxes on business out-migration, business formation, and employment.
Provides additional State school aid to school districts experiencing enrollment increases due to conversion of age-restricted housing developments to non-restricted developments.